Painful Diabetic Peripheral Neuropathy Relieved with Use of Oral Topiramate

Southern Medical Journal

Volumn 96, Issue 6, 2003, Pages 602-605

  Kline, Kristina M ^a   Carroll, Dana G ^a   Malnar, Karen F ^a  

^a UNIVERSITY OF OKLAHOMA TULSA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; GABAPENTIN; GLIPIZIDE; IBUPROFEN; METFORMIN; ROSIGLITAZONE; TOPIRAMATE; DRUG DERIVATIVE; FRUCTOSE; NEUROPROTECTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; HUMAN; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; TREATMENT OUTCOME; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PAIN;

ADMINISTRATION, ORAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FRUCTOSE; HUMANS; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PAIN;

EID: 0041382611     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000060886.57804.2E     Document Type: Article

References (13)

1. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: Current concepts in treatment. Ann Pharmacother 1995;29:769-777.
2. Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy. Drugs 2000;60:1029-1052.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
4. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880.
5. Vaillancourt PD, Langevin HM. Painful peripheral neuropathies. Med Clin North Am 1999;83:627-642.
6. Bajwa ZH, Sami N, Warfield CA, Wootton J. Topiramate relieves refractory intercostal neuralgia. Neurology 1999;52:1917.
7. Rosenfeld WE. Topiramate: A review of preclinical, pharmacokinetic, and clinical data. Clin Ther 1997;19:1294-1308.
8. Schneiderman JH. Topiramate: Pharmacokinetics and pharmacodynamics. Can J Neurol Sci 1998;25:S3-S5.
9. Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000; 55:1587-1588.
10. Potter D, Edwards R, Bennington VT. Potential role of topiramate in relief of neuropathic pain. Neurology 1998;50:A255 (abstract).
11. Jenson MG, Royal MA, Ward S, Movva V, Bhakta B, Gunyea I. Topiramate for the treatment of neuropathic and chronic pain syndromes: An open label trial. AJPM Am J Pain Manage 2002;12:12-16.
12. Misha-Miroslav B. Topiramate in the treatment of chronic neuropathic pain: A retrospective chart review. Ann Neurol 2001;1:S63-S64 (abstract).
13. Edwards KR, Glantz MJ, Button J, Norton JA, Whittaker T, Cross N, et al. Efficacy and safety of topiramate in the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled study. Neurology 2000;54:A81 (abstract).